Trastuzumab Terminated Phase 2 / 3 Trials for Metastatic Breast Cancer (MBC) Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Terminated | Treatment | 2 / 3 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT00216073 | Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer |